Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study.

Ueki, Yasushi; Yamaji, Kyohei; Barbato, Emanuele; Nef, Holger; Brugaletta, Salvatore; Alfonso, Fernando; Hill, Jonathan; Cook, Stéphane; Burzotta, Francesco; Karagiannis, Alexios; Windecker, Stephan; Räber, Lorenz (2020). Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study. Cardiovascular revascularization medicine, 21(10), pp. 1244-1250. Elsevier 10.1016/j.carrev.2020.03.023

[img] Text
Ueki_CardiovascRevascMed_2020.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (700kB) | Request a copy

PURPOSE

We investigated whether optical coherence tomography (OCT)-guided bioresorbable vascular scaffolds (BVS) implantation can improve in-scaffold minimal lumen area (MLA) at 6-month compared with angiography guidance.

METHODS

The OPTICO BVS was a randomized, international multicenter, assessor blind, superiority trial comparing OCT- versus angiography-guided percutaneous coronary intervention (PCI) (1:1 allocation) in patients with coronary artery disease undergoing Absorb BVS 1.1 implantation. The primary endpoint was in-scaffold MLA at 6-month.

RESULTS

The trial was prematurely stopped on May 31, 2017 after enrollment of 38 of 270 planned patients (14%) following the retraction of the device in Europe. Patients were randomly assigned to OCT- (n = 19) or angiography-guided PCI (n = 19). Scaffold diameter (OCT 3.0 ± 0.3 mm vs. angiography 3.1 ± 0.3 mm, P = .333) and length (28.8 ± 13.6 mm vs. 23.8 ± 12.3 mm, P = .223) were comparable. There was no significant difference in in-scaffold MLA at 6 months (4.47mm2 vs. 5.08mm2, P = .692). Scaffold expansion at 6-month was significantly higher in the OCT-guided PCI as compared with angiography-guided PCI (84.5% vs. 76.5%, P = .010). There was no significant difference in clinical outcomes.

CONCLUSIONS

Although in-scaffold MLA at 6-month did not differ between groups, scaffold expansion was improved following OCT- as compared with angiography-guided PCI. The findings of this study must be interpreted in view of the premature termination with inclusion of 14% of the initially planned study sample.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > CTU Bern

UniBE Contributor:

Ueki, Yasushi; Yamaji, Kyohei; Karagiannis Voules, Alexios; Windecker, Stephan and Räber, Lorenz

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1553-8389

Publisher:

Elsevier

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

31 Mar 2020 15:11

Last Modified:

19 Feb 2021 11:38

Publisher DOI:

10.1016/j.carrev.2020.03.023

PubMed ID:

32205067

Uncontrolled Keywords:

Bioresorbable scaffold Optical coherence tomography Percutaneous coronary intervention

BORIS DOI:

10.7892/boris.142737

URI:

https://boris.unibe.ch/id/eprint/142737

Actions (login required)

Edit item Edit item
Provide Feedback